Tablets & Capsules


Issue link:

Contents of this Issue


Page 9 of 61

8 April 2015 Tablets & Capsules growth rate, according to research from GlobalData. Factors include increasing healthcare costs, the aging population, growing prevalence of chronic lifestyle diseases such as diabetes and obesity, eas- ier access to healthcare reimbursement, and the 2010 Affordable Care Act. markets OSDF excipients to grow 6.3 percent annually ALBANY, NY—The global market for excipients used in oral solid dosage forms (OSDF), valued at $570.6 million in 2011, is projected to increase to $869.1 million by the end of 2018, a 6.3 percent annual growth rate, according to a report from Transparency Market Research. Anticipated market stimuli include greater demand for drug products from the world's geriatric population and develop- ment of excipients with better properties, such as flowability. Calcium carbonate, calcium phosphate, and polymer- and sugar-based materials are among those expected to sell robustly. The report costs $5,595. US pharma market to approach $550 billion by 2020 LONDON, UK—The US pharmaceuti- cal market will increase from an estimated value of $395.2 billion in 2014 to $548.4 billion by 2020, a 5.6 percent annual industry news FDA issues guidances to streamline ANDAs SILVER SPRING, MD—The FDA released more than three dozen new and revised draft guidances on bioequivalence to help companies develop, test, and gain approval of generic drug products. The drug-specific documents cover avanfil, lorcaserin, ivacaftor, ticagrelor, and oth- ers. They are intended to help generics manufacturers navigate the Abbreviated New Drug Application process. Your One-Stop Solution for Material Handling and Flow Problems Getting it RIGHT the First Time T: (352) 303-9123 Email: range down to 0.1 KPA, allowing direct measurement for arching. Do not rely on inherently inaccurate extrapolation for answers. If you can generate sufficient sample to run a particle size analysis, you've got a enough sample to directly measure strength with the SSSpinTester. Visit us online: Measure Bulk Strength of API at Formulation Using the science of centrifugal force, the SSSpinTester measures bulk strength of fine powders using a sample as small as 0.05 gram. Current methods of measuring the strength of a powdered material require at least one liter of sample – hard to come by in pharmaceutical and chemical industries. New technology extends the testing Alkermes to sell facility, products to Recro DUBLIN, Ireland—Alkermes agreed to sell its Gainesville, GA, manufacturing facility to Recro Pharma, Malvern, PA. The deal also transfers Alkermes' intellectual property rights to medications made at the facility, including Ritalin and Verelan. Zogenix to sell hydrocodone business SAN DIEGO, CA—Zogenix agreed to sell its Zohydro ER (hydrocodone bitar- trate) interests to Pernix Therapeutics, Morristown, NJ, for $100 million plus future earnings up to $283.5 million. The deal allows Zogenix to concentrate on two promising medications in clinical development. FDA sued over gluten in medications WASHINGTON, DC—A plantiff suffer- ing from celiac disease filed suit against the FDA for failing to regulate wheat gluten in medications. In 2008, the plain- tiff requested that the FDA ban gluten from drug products or require additional

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0415